BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms

Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...

June 04, 2025 | News

XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders

XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell the...

June 03, 2025 | News

CirCode Secures FDA IND Clearance for World’s First Circular RNA Therapy in Ischemic Heart Disease

Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline H...

June 02, 2025 | News

Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

In this interview with BioPharma APAC, Christophe Meugnier, Chief Commercial Officer and General Manager of Vietnam & Thailand at Do...

May 19, 2025 | Interview

ASPIRE Launches Fertility Health Awareness Drive Under New President Dr Haroon Latif

The Asia Pacific Initiative on Reproduction (ASPIRE) – the peak body harnessing expertise in assisted conception throughout the region – will e...

May 12, 2025 | News

Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific

Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...

May 09, 2025 | Expert Insight

Siemens Healthineers Launches MAMMOMAT B.brilliant to Advance Early Breast Cancer Detection in Indonesia

Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the...

May 02, 2025 | News

Roche Survey Calls for Immediate Action as Asia Pacific Faces Worsening Vision Health Crisis

Asia Pacific bears nearly two-thirds of the global burden of moderate-to-severe vision impairment. Although 90 percent of vision impairment is preventable ...

April 24, 2025 | News

United Kingdom’s Thriva and Tasso Partner to Tackle Needle Phobia with Painless At-Home Blood Testing

UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle n...

April 16, 2025 | News

Ascletis’ ASC30 SQ Injection Shows 36-Day Half-Life in Phase Ib Obesity Trial

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supp...

April 01, 2025 | News

AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia

Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...

March 12, 2025 | News

Gleneagles Hospital Hong Kong Becomes Asia’s First Private Hospital to Offer Histotripsy for Liver Cancer Treatment

Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative...

March 11, 2025 | News

Avecho and Sandoz Ink 10-Year Deal for Australia’s First Pharmaceutical CBD Capsule for Insomnia

Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia...

March 04, 2025 | News

Ping An Health Launches AI-Powered "Ping An Xin Yi" Digital Doctor for 24/7 Smart Healthcare

Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently annou...

February 27, 2025 | News

Stay Connected